Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol
- PMID: 6204904
Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol
Abstract
We report herein a specific, sensitive, and rapid bioassay for measuring plasma cholecystokinin in rats. Plasma was first passed through octadecylsilylsilica cartridges and the extracts were then tested for their content of cholecystokinin, based on their ability to stimulate amylase release from isolated rat pancreatic acini. Plasma levels of cholecystokinin-octapeptide as low as 0.18 pM were detectable. Gastrin, in contrast, reacted only weakly in this system. Cholecystokinin bioactivity was inhibited by the antagonist dibutyryl cyclic guanosine monophosphate and was eliminated by immunoadsorption with an antibody directed against the carboxyl terminus of cholecystokinin. Plasma cholecystokinin levels in fasting rats as cholecystokinin-octapeptide equivalents were 0.31 +/- 0.05 pM (mean +/- SE) and rose to 6.2 +/- 1.8 pM after feeding. Plasma cholecystokinin levels also increased 30-fold after intragastric instillation of soybean trypsin inhibitor and 15-fold after ethanol instillation. After column chromatography of plasma, two different forms of cholecystokinin were identifiable; one eluted with the octapeptide of cholecystokinin whereas the other most abundant form was intermediate in size between cholecystokinin-33 and cholecystokinin-octapeptide.
Similar articles
-
Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.J Clin Invest. 1985 Apr;75(4):1144-52. doi: 10.1172/JCI111809. J Clin Invest. 1985. PMID: 2580857 Free PMC article.
-
Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8.Pancreas. 1989;4(4):447-51. Pancreas. 1989. PMID: 2474813
-
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.Cancer Res. 1989 May 1;49(9):2438-41. Cancer Res. 1989. PMID: 2706631
-
Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function.Z Gastroenterol. 1991 Feb;29(2):59-64. Z Gastroenterol. 1991. PMID: 1714671
-
[Bioassay for plasma cholecystokinin bioactivity].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1991 Dec;13(6):417-21. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1991. PMID: 1724414 Chinese.
Cited by
-
Isolation and bioactivity of putative cholecystokinin-releasing peptide from rat small intestinal mucosa.Gastroenterol Jpn. 1992 Feb;27(1):83-7. doi: 10.1007/BF02775068. Gastroenterol Jpn. 1992. PMID: 1555750
-
Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin.J Clin Invest. 1986 Jun;77(6):2042-7. doi: 10.1172/JCI112534. J Clin Invest. 1986. PMID: 3711342 Free PMC article.
-
Influence of obstructive jaundice on pancreatic growth and on basal plasma levels of cholecystokinin and gastrin in rats.Dig Dis Sci. 1986 Nov;31(11):1233-41. doi: 10.1007/BF01296526. Dig Dis Sci. 1986. PMID: 2429806
-
Stimulation of pancreatic growth. Distal small bowel resection mediated by increased levels of cholecystokinin.Ann Surg. 1996 Aug;224(2):139-44. doi: 10.1097/00000658-199608000-00005. Ann Surg. 1996. PMID: 8757376 Free PMC article.
-
Pancreatic trophism in experimental liver cirrhosis.Int J Pancreatol. 1993 Oct;14(2):157-66. doi: 10.1007/BF02786122. Int J Pancreatol. 1993. PMID: 8283079
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases